Alcon (ALC) Cash from Investing Activities Growth (3y) (2021 - 2026)
Powered by 
Analysis
Alcon (ALC) Cash from Investing Activities Growth (3y) (2021 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 177.43 Bn | 172.48 Bn | 7.27 Bn | 17.83% |
| 2 | Intuitive Surgical | 139.20 Bn | 134.11 Bn | 1.96 Bn | -26.99% |
| 3 | Medtronic | 118.01 Bn | 109.81 Bn | 6.34 Bn | -44.28% |
| 4 | Stryker | 105.44 Bn | 101.96 Bn | 4.50 Bn | -6.23% |
| 5 | Boston Scientific | 62.90 Bn | 62.60 Bn | 3.85 Bn | -32.54% |
| 6 | Edwards Lifesciences | 50.87 Bn | 46.72 Bn | 1.35 Bn | -68.12% |
| 7 | Dexcom | 33.72 Bn | 31.77 Bn | 830.00 Mn | 37.39% |
| 8 | Resmed | 32.45 Bn | 30.98 Bn | 861.22 Mn | -102.03% |
| 9 | Alcon | 31.70 Bn | 30.25 Bn | 1.68 Bn | 18.69% |
| 10 | Steris | 20.01 Bn | 19.54 Bn | 684.20 Mn | -17.67% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 18.69% |
| Mar 31, 2026 | -12.04% |
| Dec 31, 2025 | 29.39% |
| Sep 30, 2025 | -7.52% |
| Jun 30, 2025 | 1.06% |
| Dec 31, 2024 | 1.74% |
| Sep 30, 2024 | -33.28% |
| Jun 30, 2024 | 36.19% |
| Mar 31, 2024 | -18.50% |
| Dec 31, 2023 | -16.26% |
| Sep 30, 2023 | -4.55% |
| Jun 30, 2023 | -62.08% |
| Mar 31, 2023 | -14.23% |
| Dec 31, 2022 | 21.06% |
| Sep 30, 2022 | -29.99% |
| Jun 30, 2022 | 45.46% |
| Mar 31, 2022 | -50.79% |
| Dec 31, 2021 | 13.38% |
| Sep 30, 2021 | -3.13% |